Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florian Guisier

Showing results (31-40 of 90) with videos related to

Pageof 9
Sort By:
Thoracic Cancer|September 2, 2022
Radial-EBUS and virtual bronchoscopy planner for peripheral lung cancer diagnosis: How it became the first-line endoscopic procedureSamy Lachkar, Loic Perrot, Diane Gervereau, et al.
Lung Cancer (Auckland, N.Z.)|August 18, 2025
Alectinib Efficacy Post-Brigatinib Against Advanced <i>ALK</i>+ Non-Small Cell Lung Cancer (BrigALK2-GFPC 02-2019 Study)Renaud Descourt, Florian Guisier, Maurice Pérol, et al.
JTO Clinical and Research Reports|February 8, 2024
Detection of Tumor DNA in Bronchoscopic Fluids in Peripheral NSCLC: A Proof-of-Concept StudyGwenaëlle Arhant, Samy Lachkar, Pierre-Alain Thiebaut, et al.
Medicine|February 4, 2020
Efficacy and safety of programmed cell-death-protein-1 and its ligand inhibitors in pretreated patients with epidermal growth-factor receptor-mutated or anaplastic lymphoma kinase-translocated lung adenocarcinomaOlivier Bylicki, Florian Guisier, Isabelle Monnet, et al.
Oncotarget|March 2, 2018
Octogenarians with EGFR-mutated non-small cell lung cancer treated by tyrosine-kinase inhibitor: a multicentric real-world study assessing tolerance and efficacy (OCTOMUT study)Romain Corre, Radj Gervais, Florian Guisier, et al.
Frontiers in Oncology|December 13, 2019
Expanding the Transcriptome of Head and Neck Squamous Cell Carcinoma Through Novel MicroRNA DiscoveryLeigha D Rock, Brenda C Minatel, Erin A Marshall, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 26, 2021
An improved assay for detection of theranostic gene translocations and MET exon 14 skipping in thoracic oncologyNicolas Piton, Marie-Delphine Lanic, Florent Marguet, et al.
Journal of Clinical Medicine|January 11, 2022
Virtual Bronchoscopy Planner and Radial-EBUS Guided Biopsy for Organizing Pneumonia DiagnosisSamy Lachkar, Mathieu Salaün, Loic Perrot, et al.
Targeted Oncology|July 25, 2018
Efficacy of Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer with Leptomeningeal Metastases Pretreated with EGFR-Tyrosine Kinase InhibitorsKarima Saboundji, Jean-Bernard Auliac, Maurice Pérol, et al.
Lung Cancer (Amsterdam, Netherlands)|September 28, 2021
Multicenter phase II trial of nintedanib plus docetaxel in second-line treatment in advanced non-squamous non-small cell lung cancer patients refractory to first-line platin-based chemotherapy (REFRACT GFPC 02-15 study)Jean-Bernard Auliac, Isabelle Monnet, Acya Bizieux, et al.
Pageof 9

Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
Thoracic Cancer|September 2, 2022
Radial-EBUS and virtual bronchoscopy planner for peripheral lung cancer diagnosis: How it became the first-line endoscopic procedureSamy Lachkar, Loic Perrot, Diane Gervereau, et al.
Lung Cancer (Auckland, N.Z.)|August 18, 2025
Alectinib Efficacy Post-Brigatinib Against Advanced <i>ALK</i>+ Non-Small Cell Lung Cancer (BrigALK2-GFPC 02-2019 Study)Renaud Descourt, Florian Guisier, Maurice Pérol, et al.
JTO Clinical and Research Reports|February 8, 2024
Detection of Tumor DNA in Bronchoscopic Fluids in Peripheral NSCLC: A Proof-of-Concept StudyGwenaëlle Arhant, Samy Lachkar, Pierre-Alain Thiebaut, et al.
Medicine|February 4, 2020
Efficacy and safety of programmed cell-death-protein-1 and its ligand inhibitors in pretreated patients with epidermal growth-factor receptor-mutated or anaplastic lymphoma kinase-translocated lung adenocarcinomaOlivier Bylicki, Florian Guisier, Isabelle Monnet, et al.
Oncotarget|March 2, 2018
Octogenarians with EGFR-mutated non-small cell lung cancer treated by tyrosine-kinase inhibitor: a multicentric real-world study assessing tolerance and efficacy (OCTOMUT study)Romain Corre, Radj Gervais, Florian Guisier, et al.
Frontiers in Oncology|December 13, 2019
Expanding the Transcriptome of Head and Neck Squamous Cell Carcinoma Through Novel MicroRNA DiscoveryLeigha D Rock, Brenda C Minatel, Erin A Marshall, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 26, 2021
An improved assay for detection of theranostic gene translocations and MET exon 14 skipping in thoracic oncologyNicolas Piton, Marie-Delphine Lanic, Florent Marguet, et al.
Journal of Clinical Medicine|January 11, 2022
Virtual Bronchoscopy Planner and Radial-EBUS Guided Biopsy for Organizing Pneumonia DiagnosisSamy Lachkar, Mathieu Salaün, Loic Perrot, et al.
Targeted Oncology|July 25, 2018
Efficacy of Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer with Leptomeningeal Metastases Pretreated with EGFR-Tyrosine Kinase InhibitorsKarima Saboundji, Jean-Bernard Auliac, Maurice Pérol, et al.
Lung Cancer (Amsterdam, Netherlands)|September 28, 2021
Multicenter phase II trial of nintedanib plus docetaxel in second-line treatment in advanced non-squamous non-small cell lung cancer patients refractory to first-line platin-based chemotherapy (REFRACT GFPC 02-15 study)Jean-Bernard Auliac, Isabelle Monnet, Acya Bizieux, et al.
Pageof 9